At-Home Medical Testing Soon to Launch, says Amazon

Amazon is reportedly considering launching a program that provides at-home medical exams, marking the company’s latest foray into healthcare. According to Insider, Amazon is considering releasing a COVID-19 at-home testing kit in June, as well as respiratory and sexually transmitted infection testing kits.Eugene Kim from Insider reported, “Amazon’s long-term goal is to expand into other areas, such as clinical genomics, and launch a third-party marketplace that sells medical tests from other companies.” Internally, the 300-person team behind the campaign is known as “Amazon Diagnostics,” according to Insider. Amazon has already spent hundreds of millions of dollars on COVID-19 employee training to increase capacity to 50,000 tests a day.

In March, the company received FDA approval for its COVID-19 tests that can be performed at home. A diagnostics project, according to sources, may help it build on such investments in the long run. Amazon’s first COVID-19 trial kit could launch on Prime Day, with a tentative start date of June 21. According to news, Amazon Diagnostics has many long-term ambitions, including a third-party platform for home and genomic research.Meanwhile, reports say that the proposals are still being discussed – and that they could be scrapped entirely. Amazon has made many attempts to break into the healthcare sector, some of which have been more successful than others.

This year, it disbanded its much-hyped Haven alliance with JPMorgan Chase and Berkshire-Hathaway, putting an end to speculation about how the initiative could disrupt the healthcare landscape. Despite this, the company has continued to experiment, introducing several health-related Alexa features and a digital pharmacy. There’s also Amazon Care, the company’s telehealth initiative that will soon provide app-based services in all 50 states.Amazon is reportedly considering launching a program that provides at-home medical exams, marking the company’s latest foray into healthcare. According to Insider, Amazon is considering releasing a COVID-19 at-home testing kit in June, as well as respiratory and sexually transmitted infection testing kits.

Eugene Kim from Insider reported, “Amazon long-term goal is to expand into other areas, such as clinical genomics, and launch a third-party marketplace that sells medical tests from other companies.” Internally, the 300-person team behind the campaign is known as “Amazon Diagnostics,” according to Insider. Amazon has already spent hundreds of millions of dollars on COVID-19 employee training to increase capacity to 50,000 tests a day.In March, the company received FDA approval for its COVID-19 tests that can be performed at home. A diagnostics project, according to sources, may help it build on such investments in the long run. Amazon’s first COVID-19 trial kit could launch on Prime Day, with a tentative start date of June 21. According to news, Amazon Diagnostics has many long-term ambitions, including a third-party platform for home and genomic research.

Meanwhile, reports say that the proposals are still being discussed – and that they could be scrapped entirely. Amazon has made many attempts to break into the healthcare sector, some of which have been more successful than others.This year, it disbanded its much-hyped Haven alliance with JPMorgan Chase and Berkshire-Hathaway, putting an end to speculation about how the initiative could disrupt the healthcare landscape. Despite this, the company has continued to experiment, introducing several health-related Alexa features and a digital pharmacy. There’s also Amazon Care, the company’s telehealth initiative that will soon provide app-based services in all 50 states.